Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023

Upgrades

According to OTR Global, the prior rating for Ritchie Bros Auctioneers Inc RBA was changed from Mixed to Positive. For the fourth quarter, Ritchie Bros Auctioneers had an EPS of $0.68, compared to year-ago quarter EPS of $0.50. The current stock performance of Ritchie Bros Auctioneers shows a 52-week-high of $72.68 and a 52-week-low of $48.75. Moreover, at the end of the last trading period, the closing price was at $56.27.

For Louisiana-Pacific Corp LPX, TD Cowen upgraded the previous rating of Hold to Buy. In the first quarter, Louisiana-Pacific showed an EPS of $0.34, compared to $5.08 from the year-ago quarter. The current stock performance of Louisiana-Pacific shows a 52-week-high of $78.09 and a 52-week-low of $48.20. Moreover, at the end of the last trading period, the closing price was at $61.97.

For Builders FirstSource Inc BLDR, RBC Capital upgraded the previous rating of Sector Perform to Outperform. For the first quarter, Builders FirstSource had an EPS of $2.96, compared to year-ago quarter EPS of $3.90. The stock has a 52-week-high of $107.81 and a 52-week-low of $48.94. At the end of the last trading period, Builders FirstSource closed at $107.46.

For Verisk Analytics Inc VRSK, B of A Securities upgraded the previous rating of Underperform to Buy. In the first quarter, Verisk Analytics showed an EPS of $1.29, compared to $1.34 from the year-ago quarter. The current stock performance of Verisk Analytics shows a 52-week-high of $206.89 and a 52-week-low of $156.07. Moreover, at the end of the last trading period, the closing price was at $203.97.

For Ionis Pharmaceuticals Inc IONS, Citigroup upgraded the previous rating of Sell to Neutral. For the first quarter, Ionis Pharmaceuticals had an EPS of $0.68, compared to year-ago quarter EPS of $0.27. The stock has a 52-week-high of $48.82 and a 52-week-low of $31.46. At the end of the last trading period, Ionis Pharmaceuticals closed at $34.73.

For Neurocrine Biosciences Inc NBIX, Guggenheim upgraded the previous rating of Neutral to Buy. Neurocrine Biosciences earned $0.51 in the first quarter, compared to $0.30 in the year-ago quarter. The current stock performance of Neurocrine Biosciences shows a 52-week-high of $129.00 and a 52-week-low of $75.27. Moreover, at the end of the last trading period, the closing price was at $98.62.

According to Summit Insights Group, the prior rating for Qorvo Inc QRVO was changed from Hold to Buy. Qorvo earned $0.26 in the fourth quarter, compared to $3.12 in the year-ago quarter. At the moment, the stock has a 52-week-high of $121.21 and a 52-week-low of $75.58. Qorvo closed at $93.62 at the end of the last trading period.

For Procore Technologies Inc PCOR, Goldman Sachs upgraded the previous rating of Neutral to Buy. Procore Technologies earned $0.01 in the first quarter, compared to $0.15 in the year-ago quarter. The current stock performance of Procore Technologies shows a 52-week-high of $68.56 and a 52-week-low of $40.12. Moreover, at the end of the last trading period, the closing price was at $53.18.

TD Securities upgraded the previous rating for Louisiana-Pacific Corp LPX from Hold to Buy. For the first quarter, Louisiana-Pacific had an EPS of $0.34, compared to year-ago quarter EPS of $5.08. The current stock performance of Louisiana-Pacific shows a 52-week-high of $78.09 and a 52-week-low of $48.20. Moreover, at the end of the last trading period, the closing price was at $61.97.

According to Wells Fargo, the prior rating for Cerevel Therapeutics Holdings Inc CERE was changed from Equal-Weight to Overweight. Cerevel Therapeutics Hldg earned $0.67 in the first quarter, compared to $0.46 in the year-ago quarter. The stock has a 52-week-high of $41.43 and a 52-week-low of $19.88. At the end of the last trading period, Cerevel Therapeutics Hldg closed at $31.92.

According to B. Riley Securities, the prior rating for Hersha Hospitality Trust HT was changed from Neutral to Buy. In the first quarter, Hersha Hospitality showed an EPS of $0.02, compared to $0.06 from the year-ago quarter. The current stock performance of Hersha Hospitality shows a 52-week-high of $12.13 and a 52-week-low of $5.75. Moreover, at the end of the last trading period, the closing price was at $6.02.

For Green Brick Partners Inc GRBK, B. Riley Securities upgraded the previous rating of Neutral to Buy. Green Brick Partners earned $1.37 in the first quarter, compared to $1.20 in the year-ago quarter. The current stock performance of Green Brick Partners shows a 52-week-high of $38.13 and a 52-week-low of $16.80. Moreover, at the end of the last trading period, the closing price was at $37.17.

For Blackbaud Inc BLKB, Baird upgraded the previous rating of Neutral to Outperform. In the first quarter, Blackbaud showed an EPS of $0.72, compared to $0.57 from the year-ago quarter. At the moment, the stock has a 52-week-high of $69.77 and a 52-week-low of $43.54. Blackbaud closed at $67.33 at the end of the last trading period.

According to Raymond James, the prior rating for Weave Communications Inc WEAV was changed from Market Perform to Outperform. In the first quarter, Weave Communications showed an EPS of $0.05, compared to $0.16 from the year-ago quarter. The stock has a 52-week-high of $6.93 and a 52-week-low of $2.99. At the end of the last trading period, Weave Communications closed at $4.26.

According to Raymond James, the prior rating for Wix.com Ltd WIX was changed from Market Perform to Outperform. For the fourth quarter, Wix.com had an EPS of $0.61, compared to year-ago quarter EPS of $0.37. The current stock performance of Wix.com shows a 52-week-high of $101.55 and a 52-week-low of $53.12. Moreover, at the end of the last trading period, the closing price was at $75.36.

According to Goldman Sachs, the prior rating for Design Therapeutics Inc DSGN was changed from Sell to Neutral. In the fourth quarter, Design Therapeutics showed an EPS of $0.31, compared to $0.20 from the year-ago quarter. At the moment, the stock has a 52-week-high of $26.30 and a 52-week-low of $4.90. Design Therapeutics closed at $7.19 at the end of the last trading period.

According to Goldman Sachs, the prior rating for Cemex SAB de CV CX was changed from Neutral to Buy. Cemex earned $0.15 in the first quarter, compared to $0.13 in the year-ago quarter. The stock has a 52-week-high of $6.73 and a 52-week-low of $3.20. At the end of the last trading period, Cemex closed at $6.31.

See all analyst ratings upgrades.

Downgrades

According to B of A Securities, the prior rating for Upwork Inc UPWK was changed from Buy to Neutral. Upwork earned $0.01 in the first quarter, compared to $0.03 in the year-ago quarter. The stock has a 52-week-high of $25.05 and a 52-week-low of $7.95. At the end of the last trading period, Upwork closed at $8.14.

For Incyte Corp INCY, B of A Securities downgraded the previous rating of Buy to Neutral. Incyte earned $0.37 in the first quarter, compared to $0.55 in the year-ago quarter. At the moment, the stock has a 52-week-high of $86.29 and a 52-week-low of $65.07. Incyte closed at $68.04 at the end of the last trading period.

For QuinStreet Inc QNST, Craig-Hallum downgraded the previous rating of Buy to Hold. In the third quarter, QuinStreet showed an EPS of $0.11, compared to $0.09 from the year-ago quarter. The stock has a 52-week-high of $18.18 and a 52-week-low of $8.29. At the end of the last trading period, QuinStreet closed at $9.70.

Susquehanna downgraded the previous rating for Frontier Group Holdings Inc ULCC from Positive to Neutral. Frontier Group Holdings earned $0.05 in the first quarter, compared to $0.50 in the year-ago quarter. At the moment, the stock has a 52-week-high of $15.24 and a 52-week-low of $8.19. Frontier Group Holdings closed at $9.54 at the end of the last trading period.

DA Davidson downgraded the previous rating for PacWest Bancorp PACW from Buy to Neutral. In the first quarter, PacWest Banc showed an EPS of $0.66, compared to $1.01 from the year-ago quarter. The stock has a 52-week-high of $34.68 and a 52-week-low of $5.00. At the end of the last trading period, PacWest Banc closed at $6.42.

According to Wedbush, the prior rating for Diebold Nixdorf Inc DBD was changed from Outperform to Neutral. Diebold Nixdorf earned $0.85 in the first quarter, compared to $1.61 in the year-ago quarter. The stock has a 52-week-high of $5.26 and a 52-week-low of $0.44. At the end of the last trading period, Diebold Nixdorf closed at $0.45.

For SiTime Corp SITM, Needham downgraded the previous rating of Buy to Hold. For the first quarter, SiTime had an EPS of $0.09, compared to year-ago quarter EPS of $0.94. At the moment, the stock has a 52-week-high of $234.44 and a 52-week-low of $73.10. SiTime closed at $106.54 at the end of the last trading period.

According to TD Cowen, the prior rating for Spirit AeroSystems Holdings Inc SPR was changed from Outperform to Market Perform. For the first quarter, Spirit AeroSystems Hldgs had an EPS of $1.69, compared to year-ago quarter EPS of $0.03. The current stock performance of Spirit AeroSystems Hldgs shows a 52-week-high of $43.50 and a 52-week-low of $21.15. Moreover, at the end of the last trading period, the closing price was at $26.28.

For TriplePoint Venture Growth BDC Corp TPVG, Wells Fargo downgraded the previous rating of Overweight to Equal-Weight. For the first quarter, TriplePoint Venture Gwth had an EPS of $0.53, compared to year-ago quarter EPS of $0.44. The stock has a 52-week-high of $16.37 and a 52-week-low of $10.10. At the end of the last trading period, TriplePoint Venture Gwth closed at $10.73.

For Builders FirstSource Inc BLDR, Baird downgraded the previous rating of Outperform to Neutral. For the first quarter, Builders FirstSource had an EPS of $2.96, compared to year-ago quarter EPS of $3.90. At the moment, the stock has a 52-week-high of $107.81 and a 52-week-low of $48.94. Builders FirstSource closed at $107.46 at the end of the last trading period.

According to Baird, the prior rating for IVERIC bio Inc ISEE was changed from Outperform to Neutral. For the fourth quarter, IVERIC bio had an EPS of $0.47, compared to year-ago quarter EPS of $0.29. At the moment, the stock has a 52-week-high of $38.25 and a 52-week-low of $8.88. IVERIC bio closed at $37.21 at the end of the last trading period.

According to Raymond James, the prior rating for Revolve Group Inc RVLV was changed from Outperform to Market Perform. In the first quarter, Revolve Gr showed an EPS of $0.19, compared to $0.30 from the year-ago quarter. The stock has a 52-week-high of $44.32 and a 52-week-low of $19.71. At the end of the last trading period, Revolve Gr closed at $20.01.

According to Citigroup, the prior rating for Wingstop Inc WING was changed from Buy to Neutral. For the first quarter, Wingstop had an EPS of $0.59, compared to year-ago quarter EPS of $0.34. The stock has a 52-week-high of $221.30 and a 52-week-low of $67.75. At the end of the last trading period, Wingstop closed at $217.95.

According to Goldman Sachs, the prior rating for Fulcrum Therapeutics Inc FULC was changed from Buy to Neutral. In the fourth quarter, Fulcrum Therapeutics showed an EPS of $0.50, compared to $0.58 from the year-ago quarter. The current stock performance of Fulcrum Therapeutics shows a 52-week-high of $15.00 and a 52-week-low of $2.25. Moreover, at the end of the last trading period, the closing price was at $2.93.

According to Jefferies, the prior rating for DHT Holdings Inc DHT was changed from Buy to Hold. For the first quarter, DHT Holdings had an EPS of $0.23, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $12.13 and a 52-week-low of $4.99. At the end of the last trading period, DHT Holdings closed at $9.03.

See all analyst ratings downgrades.

Initiations

With a Buy rating, UBS initiated coverage on Ferguson PLC FERG. The price target seems to have been set at $165.00 for Ferguson. For the second quarter, Ferguson had an EPS of $1.91, compared to year-ago quarter EPS of $1.93. At the moment, the stock has a 52-week-high of $149.81 and a 52-week-low of $99.24. Ferguson closed at $139.50 at the end of the last trading period.

With a Buy rating, HC Wainwright & Co. initiated coverage on Absci Corp ABSI. The price target seems to have been set at $4.00 for Absci. Absci earned $0.21 in the fourth quarter, compared to $0.28 in the year-ago quarter. The stock has a 52-week-high of $7.03 and a 52-week-low of $1.17. At the end of the last trading period, Absci closed at $1.25.

DA Davidson initiated coverage on ZoomInfo Technologies Inc ZI with a Buy rating. The price target for ZoomInfo Technologies is set to $30.00. ZoomInfo Technologies earned $0.24 in the first quarter, compared to $0.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $54.42 and a 52-week-low of $20.72. ZoomInfo Technologies closed at $21.45 at the end of the last trading period.

See all analyst ratings initiations.